Patent · US Active

Compounds

US7655693B2 · kind B2 · utility

12Cited by

4References

14Claims

0Family size

Assignee

Glaxo Group Limited · GB

Inventors

Giuseppe Alvaro · Stevenage, GB
Markus Bergauer · Verona, IT
Roberto Profeta · Verona, IT
Riccardo Giovannini · Verona, IT

Key dates

Filing date	Oct 6, 2006
Grant date	Feb 2, 2010
Priority date	—
Expiry date	Jul 15, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a compound of formula (I), pharmaceutical compositions thereof, and methods of treatment using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.